Search Login Register

3-Tyr-octreotide Summary

25 relevant articles (1 outcomes, 7 trials/studies) found for this Bio-Agent

Description: cyclic octapeptide analog of somatostatin; potent somatostatin agonist; RN given refers to (R-(R*,R*))-isomer; RN for cpd without isomeric designation not avail 3/90

Also Known As: (Tyr(3))octreotide; 204-090; SMS 201-995, Tyr(3)-; SMS 204-090; SMS-204-090 Show All >>

Key Diseases for which 3-Tyr-octreotide is Relevant

  1. Neoplasms (Cancer) : 1 outcome 5 studies in 18 results
  2. Neoplasm Metastasis (Metastasis) : 1 study in 2 results
  3. Carcinoid Tumor (Carcinoid) : 1 study in 2 results
  4. Lymphoma (Lymphomas) : 1 study in 1 result
  5. Leukemia : 1 study in 1 result
Show All >>

Drugs Related to 3-Tyr-octreotide

  1. Somatostatin Receptors (Somatostatin Receptor)
  2. yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acid
  3. (DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)
  4. Octreotide (Sandostatin)
  5. Pentetic Acid (DTPA)
  6. Somatostatin (Somatotropin Release-Inhibiting Factor)
  7. Tyr(3)- octreotate
  8. EDDA (NiEDDA)
  9. Chromogranin A
  10. Peptide Receptors (Peptide Receptor)
Show All >>

Therapies Related to 3-Tyr-octreotide


CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.